X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare SHASUN PHARMA with GSK Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SHASUN PHARMA vs GSK PHARMA - Comparison Results

GSK PHARMA 
   Change

GSK Pharma is one of the leading MNC pharma companies in the Indian market. It is a 50.7% subsidiary of GlaxoSmithKline Plc, one of the world's largest pharma companies. GSK Pharma's product portfolio boasts of some of the leading brands like Augment... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SHASUN PHARMA GSK PHARMA SHASUN PHARMA/
GSK PHARMA
 
P/E (TTM) x 123.9 59.5 208.3% View Chart
P/BV x 8.5 11.7 73.2% View Chart
Dividend Yield % 0.2 2.1 11.0%  

Financials

 SHASUN PHARMA   GSK PHARMA
EQUITY SHARE DATA
    SHASUN PHARMA
Mar-14
GSK PHARMA
Mar-16
SHASUN PHARMA/
GSK PHARMA
5-Yr Chart
Click to enlarge
High Rs943,850 2.4%   
Low Rs462,966 1.5%   
Sales per share (Unadj.) Rs214.2332.3 64.4%  
Earnings per share (Unadj.) Rs5.344.3 12.0%  
Cash flow per share (Unadj.) Rs15.847.2 33.5%  
Dividends per share (Unadj.) Rs1.0050.00 2.0%  
Dividend yield (eoy) %1.41.5 97.5%  
Book value per share (Unadj.) Rs53.3202.7 26.3%  
Shares outstanding (eoy) m56.6284.70 66.8%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.310.3 3.2%   
Avg P/E ratio x13.176.9 17.0%  
P/CF ratio (eoy) x4.472.2 6.1%  
Price / Book Value ratio x1.316.8 7.8%  
Dividend payout %18.7112.9 16.6%   
Avg Mkt Cap Rs m3,958288,643 1.4%   
No. of employees `000NA4.6 0.0%   
Total wages/salary Rs m2,1644,434 48.8%   
Avg. sales/employee Rs ThNM6,104.5-  
Avg. wages/employee Rs ThNM961.6-  
Avg. net profit/employee Rs ThNM813.7-  
INCOME DATA
Net Sales Rs m12,12728,148 43.1%  
Other income Rs m2291,218 18.8%   
Total revenues Rs m12,35629,366 42.1%   
Gross profit Rs m1,0094,774 21.1%  
Depreciation Rs m594248 239.4%   
Interest Rs m4150-   
Profit before tax Rs m2305,744 4.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m026 0.0%   
Tax Rs m-732,018 -3.6%   
Profit after tax Rs m3023,752 8.1%  
Gross profit margin %8.317.0 49.1%  
Effective tax rate %-31.735.1 -90.1%   
Net profit margin %2.513.3 18.7%  
BALANCE SHEET DATA
Current assets Rs m6,88421,462 32.1%   
Current liabilities Rs m8,45610,536 80.3%   
Net working cap to sales %-13.038.8 -33.4%  
Current ratio x0.82.0 40.0%  
Inventory Days Days6268 91.1%  
Debtors Days Days10816 655.1%  
Net fixed assets Rs m4,9704,717 105.4%   
Share capital Rs m113847 13.4%   
"Free" reserves Rs m2,87516,308 17.6%   
Net worth Rs m3,02017,171 17.6%   
Long term debt Rs m1,81716 11,358.8%   
Total assets Rs m13,34730,620 43.6%  
Interest coverage x1.6NM-  
Debt to equity ratio x0.60 64,580.5%  
Sales to assets ratio x0.90.9 98.8%   
Return on assets %5.412.3 43.9%  
Return on equity %10.021.9 45.8%  
Return on capital %13.333.6 39.7%  
Exports to sales %46.40 326,205.1%   
Imports to sales %14.215.1 94.6%   
Exports (fob) Rs m5,6224 140,537.5%   
Imports (cif) Rs m1,7284,237 40.8%   
Fx inflow Rs m5,843519 1,125.7%   
Fx outflow Rs m2,1738,320 26.1%   
Net fx Rs m3,669-7,801 -47.0%   
CASH FLOW
From Operations Rs m3981,386 28.7%  
From Investments Rs m-1,6355,010 -32.6%  
From Financial Activity Rs m1,309-6,383 -20.5%  
Net Cashflow Rs m7112 603.4%  

Share Holding

Indian Promoters % 39.2 0.0 -  
Foreign collaborators % 0.0 50.7 -  
Indian inst/Mut Fund % 3.6 10.2 35.3%  
FIIs % 17.6 23.8 73.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 39.6 15.4 257.1%  
Shareholders   20,750 102,036 20.3%  
Pledged promoter(s) holding % 12.3 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SHASUN PHARMA With:   ALEMBIC LTD  SUN PHARMA  PFIZER  FDC LTD.  AUROBINDO PHARMA  

Compare SHASUN PHARMA With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Strong Note; Tata Global Beverages Surges 8.3%(Closing)

Indian share markets snapped their losing streak of last week and finished the trading day on a strong note due to strong buying momentum in FMCG stocks, metal stocks and auto stocks.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

Proxy Plays: A Smart Way to Bet on 'Off Limits' Companies(The 5 Minute Wrapup)

Aug 4, 2017

The small-cap space is full of small players that are clear proxies to great growth stories and Indian megatrends.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SHASUN PHARMA SHARE PRICE


Nov 17, 2015 (Close)

TRACK SHASUN PHARMA

  • Track your investment in SHASUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SHASUN PHARMA 5-YR ANALYSIS

COMPARE SHASUN PHARMA WITH

MARKET STATS